|
Ä¿¸®¾îÄɾî |
´Ù±¹ÀûÁ¦¾àȸ»ç CSO (Clinical Safety Officer)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
09.27 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀ§CRO»ç-BD ¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.26 |
|
|
(ÁÖ)ÇÇ¿¥ÆÄ¿ö |
±¹³»´ë±â¾÷Á¦¾àȸ»ç ÀÓ»óCRA´ë¸®±Þ°æ·ÂÀÚ¸ðÁý
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.25 |
|
|
scout |
CRM °æ·Â -[À¯¸í ±Û·Î¹ú CRO]
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
02.04 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Clinical Research Science(Â÷Àå±Þ)±¹³»MajorÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
06.25 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀ§Á¦¾à»ç ÀÓ»óÃÑ°ýÃ¥ÀÓÀÚ ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.30 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¿Ü±¹°èÁ¦¾à»ç CRA/CTM ¸ðÁý
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.22 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹Àû ¼±µÎÁ¦¾à»ç PV (Pharmacovigilance) Specialist
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
02.16 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¿ÜÀÚCRO»ç-DM ¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.18 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀ§CRO»ç-BD¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.04 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
¿ÜÀÚCRO-Clinical Project Manager
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.26 |
|
|
¾Æµ¥ÄÚÄÚ¸®¾Æ |
[±Û·Î¹úCRO] ´ë±Ô¸ð CRA °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.25 |
|
|
GNK Inc |
cra, crm °æ·ÂÁ÷ ¸ð½Ê´Ï´Ù.
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
06.13 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹ÀûÁ¦¾àȸ»ç CPL (Clinical Project Leader)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
09.27 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
Àü¹®Á¦¾à»ç CRA ¾÷¹«
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.16 |
|